Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Conor Shareholders OK $1.4B J&J Buyout - Medical Product Outsourcing

Conor Shareholders OK $1.4B J&J Buyout

The shareholders of Conor Medsystems of Menlo Park, CA approved Wednesday a $1.4 billion takeover of the  company by New Brunswick, NJ-based Johnson & Johnson.

One of the main attractions of the medical device giant was Conor Medsystems’ next-generation drug-coated stent, CoStar, which is sold outside the U.S. and is currently in U.S. clinical trials. J&J now sells the Cypher drug-coated stent, which competes with Natick, MA-based Boston Scientific’s Taxus line.

Conor Medsystems claims that the CoStar, which uses paclitaxel, is different from other drug-coated stents, in that it uses tiny reservoirs built into the stent to release the drug.

Conor shares rose 13 cents to $33.35 in electronic after-hours activity, after climbing 8 cents to close at $33.22 on the Nasdaq.

Add us as a preferred source on Google

Get the latest Medical Product Outsourcing news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters